Theratechnologies Inc.
TSX : TH

Theratechnologies Inc.

May 15, 2015 10:59 ET

Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted

MONTREAL, CANADA--(Marketwired - May 15, 2015) - Theratechnologies Inc. (TSX:TH) today announced that the Superior Court of Québec has authorized 121851 Canada Inc. to discontinue all class action proceedings filed pursuant to the Securities Act (Québec) and the Civil Code of Québec against the Company, a director and a former president and chief executive officer.

The authorization to discontinue the proceedings against the Company, a director and a former president and chief executive officer results from the April 17, 2015 decision of the Supreme Court of Canada.

The discontinuation of the proceedings by 121851 Canada Inc. in relation to this litigation will become effective on May 19, 2015.

About Theratechnologies

Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and improved quality of life. Further information about Theratechnologies is available on the Company's website at www.theratech.com, and on SEDAR at www.sedar.

Contact Information

  • Theratechnologies Inc.
    Jocelyn Lafond
    514-336-7800 (ext. 288)